Predictive Rules of Efflux Inhibition and Avoidance in Pseudomonas aeruginosa
Copyright © 2021 Mehla et al..
Antibiotic-resistant bacteria rapidly spread in clinical and natural environments and challenge our modern lifestyle. A major component of defense against antibiotics in Gram-negative bacteria is a drug permeation barrier created by active efflux across the outer membrane. We identified molecular determinants defining the propensity of small peptidomimetic molecules to avoid and inhibit efflux pumps in Pseudomonas aeruginosa, a human pathogen notorious for its antibiotic resistance. Combining experimental and computational protocols, we mapped the fate of the compounds from structure-activity relationships through their dynamic behavior in solution, permeation across both the inner and outer membranes, and interaction with MexB, the major efflux transporter of P. aeruginosa We identified predictors of efflux avoidance and inhibition and demonstrated their power by using a library of traditional antibiotics and compound series and by generating new inhibitors of MexB. The identified predictors will enable the discovery and optimization of antibacterial agents suitable for treatment of P. aeruginosa infections.IMPORTANCE Efflux pump avoidance and inhibition are desired properties for the optimization of antibacterial activities against Gram-negative bacteria. However, molecular and physicochemical interactions defining the interface between compounds and efflux pumps remain poorly understood. We identified properties that correlate with efflux avoidance and inhibition, are predictive of similar features in structurally diverse compounds, and allow researchers to distinguish between efflux substrates, inhibitors, and avoiders in P. aeruginosa The developed predictive models are based on the descriptors representative of different clusters comprising a physically intuitive combination of properties. Molecular shape (represented by acylindricity), amphiphilicity (anisotropic polarizability), aromaticity (number of aromatic rings), and the partition coefficient (LogD) are physicochemical predictors of efflux inhibitors, whereas interactions with Pro668 and Leu674 residues of MexB distinguish between inhibitors/substrates and efflux avoiders. The predictive models and efflux rules are applicable to compounds with unrelated chemical scaffolds and pave the way for development of compounds with the desired efflux interface properties.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:12 |
|---|---|
| Enthalten in: |
mBio - 12(2021), 1 vom: 19. Jan. |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Mehla, Jitender [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 10.09.2021 Date Revised 10.09.2021 published: Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1128/mBio.02785-20 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM320311066 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM320311066 | ||
| 003 | DE-627 | ||
| 005 | 20231225173314.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1128/mBio.02785-20 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1067.xml |
| 035 | |a (DE-627)NLM320311066 | ||
| 035 | |a (NLM)33468691 | ||
| 035 | |a (PII)e02785-20 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Mehla, Jitender |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Predictive Rules of Efflux Inhibition and Avoidance in Pseudomonas aeruginosa |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 10.09.2021 | ||
| 500 | |a Date Revised 10.09.2021 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2021 Mehla et al. | ||
| 520 | |a Antibiotic-resistant bacteria rapidly spread in clinical and natural environments and challenge our modern lifestyle. A major component of defense against antibiotics in Gram-negative bacteria is a drug permeation barrier created by active efflux across the outer membrane. We identified molecular determinants defining the propensity of small peptidomimetic molecules to avoid and inhibit efflux pumps in Pseudomonas aeruginosa, a human pathogen notorious for its antibiotic resistance. Combining experimental and computational protocols, we mapped the fate of the compounds from structure-activity relationships through their dynamic behavior in solution, permeation across both the inner and outer membranes, and interaction with MexB, the major efflux transporter of P. aeruginosa We identified predictors of efflux avoidance and inhibition and demonstrated their power by using a library of traditional antibiotics and compound series and by generating new inhibitors of MexB. The identified predictors will enable the discovery and optimization of antibacterial agents suitable for treatment of P. aeruginosa infections.IMPORTANCE Efflux pump avoidance and inhibition are desired properties for the optimization of antibacterial activities against Gram-negative bacteria. However, molecular and physicochemical interactions defining the interface between compounds and efflux pumps remain poorly understood. We identified properties that correlate with efflux avoidance and inhibition, are predictive of similar features in structurally diverse compounds, and allow researchers to distinguish between efflux substrates, inhibitors, and avoiders in P. aeruginosa The developed predictive models are based on the descriptors representative of different clusters comprising a physically intuitive combination of properties. Molecular shape (represented by acylindricity), amphiphilicity (anisotropic polarizability), aromaticity (number of aromatic rings), and the partition coefficient (LogD) are physicochemical predictors of efflux inhibitors, whereas interactions with Pro668 and Leu674 residues of MexB distinguish between inhibitors/substrates and efflux avoiders. The predictive models and efflux rules are applicable to compounds with unrelated chemical scaffolds and pave the way for development of compounds with the desired efflux interface properties | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, N.I.H., Extramural | |
| 650 | 4 | |a Research Support, U.S. Gov't, Non-P.H.S. | |
| 650 | 4 | |a Pseudomonas aeruginosa | |
| 650 | 4 | |a antibiotic resistance | |
| 650 | 4 | |a machine learning models | |
| 650 | 4 | |a multidrug efflux | |
| 650 | 4 | |a outer membrane | |
| 650 | 7 | |a Anti-Bacterial Agents |2 NLM | |
| 650 | 7 | |a Bacterial Outer Membrane Proteins |2 NLM | |
| 650 | 7 | |a Membrane Transport Proteins |2 NLM | |
| 650 | 7 | |a MexB protein, Pseudomonas aeruginosa |2 NLM | |
| 650 | 7 | |a Peptidomimetics |2 NLM | |
| 700 | 1 | |a Malloci, Giuliano |e verfasserin |4 aut | |
| 700 | 1 | |a Mansbach, Rachael |e verfasserin |4 aut | |
| 700 | 1 | |a López, Cesar A |e verfasserin |4 aut | |
| 700 | 1 | |a Tsivkovski, Ruslan |e verfasserin |4 aut | |
| 700 | 1 | |a Haynes, Keith |e verfasserin |4 aut | |
| 700 | 1 | |a Leus, Inga V |e verfasserin |4 aut | |
| 700 | 1 | |a Grindstaff, Sally B |e verfasserin |4 aut | |
| 700 | 1 | |a Cascella, Robert H |e verfasserin |4 aut | |
| 700 | 1 | |a D'Cunha, Napoleon |e verfasserin |4 aut | |
| 700 | 1 | |a Herndon, Liam |e verfasserin |4 aut | |
| 700 | 1 | |a Hengartner, Nicolas W |e verfasserin |4 aut | |
| 700 | 1 | |a Margiotta, Enrico |e verfasserin |4 aut | |
| 700 | 1 | |a Atzori, Alessio |e verfasserin |4 aut | |
| 700 | 1 | |a Vargiu, Attilio V |e verfasserin |4 aut | |
| 700 | 1 | |a Manrique, Pedro D |e verfasserin |4 aut | |
| 700 | 1 | |a Walker, John K |e verfasserin |4 aut | |
| 700 | 1 | |a Lomovskaya, Olga |e verfasserin |4 aut | |
| 700 | 1 | |a Ruggerone, Paolo |e verfasserin |4 aut | |
| 700 | 1 | |a Gnanakaran, S |e verfasserin |4 aut | |
| 700 | 1 | |a Rybenkov, Valentin V |e verfasserin |4 aut | |
| 700 | 1 | |a Zgurskaya, Helen I |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t mBio |d 2010 |g 12(2021), 1 vom: 19. Jan. |w (DE-627)NLM200128191 |x 2150-7511 |7 nnns |
| 773 | 1 | 8 | |g volume:12 |g year:2021 |g number:1 |g day:19 |g month:01 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1128/mBio.02785-20 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 12 |j 2021 |e 1 |b 19 |c 01 | ||